跳转至内容
Merck
所有图片(1)

主要文件

查看所有文档

SML2620

Sigma-Aldrich

Bromonoscapine

≥98% (HPLC)

别名:

(S)-3-((R)-9-bromo-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-6,7-dimethoxyisobenzofuran-1(3H)-one, 9-Bromonoscapine, EM 011

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C22H22BrNO7
CAS号:
488721-01-3
分子量:
492.32
MDL编号:
MFCD28969854
UNSPSC代码:
12352200
NACRES:
NA.77

方案

≥98% (HPLC)

表单

powder

旋光性

[α]/D -100 to -120°, c = 1 in dichloromethane

颜色

faint yellow to dark orange

溶解性

DMSO: 2 mg/mL, clear

储存温度

2-8°C

SMILES字符串

Brc1c2c(c(c3c1CCN([C@H]3[C@H]4OC(=O)c5c4ccc(c5OC)OC)C)OC)OCO2

InChI

1S/C22H22BrNO7/c1-24-8-7-10-13(19(28-4)21-20(15(10)23)29-9-30-21)16(24)17-11-5-6-12(26-2)18(27-3)14(11)22(25)31-17/h5-6,16-17H,7-9H2,1-4H3/t16-,17+/m1/s1

InChI key

PLMUFLAOTAHIIZ-SJORKVTESA-N

生化/生理作用

Bromonoscapine is a microtubular disrupting agent that exhibits potent cytotoxic activity against breast, lung and other cancers.
microtubular disrupting agent

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Akhilesh Kumar Verma et al.
Bioorganic & medicinal chemistry, 14(19), 6733-6736 (2006-06-21)
Three haloderivatives of noscapine 2-4 were synthesized chemoselectively and their in vitro cytotoxicity was assessed by MTT assay on U-87 human glioblastoma cell lines. At 50 microM concentration after 72 h, 9-chloronoscapine 2, 9-bromonoscapine 3 (EM011), and 9-iodonoscapine 4 killed
Jun Zhou et al.
Molecular pharmacology, 63(4), 799-807 (2003-03-20)
Noscapine, a microtubule-interfering agent, has been shown to arrest mitosis, to induce apoptosis, and to have potent antitumor activity. We report herein that two brominated derivatives of noscapine, 5-bromonoscapine (5-Br-nosc) and reduced 5-bromonoscapine (Rd 5-Br-nosc), have higher tubulin binding activity
Maged Henary et al.
Biochemical pharmacology, 92(2), 192-205 (2014-08-16)
Noscapine, an opium-derived 'kinder-gentler' microtubule-modulating drug is in Phase I/II clinical trials for cancer chemotherapy. However, its limited water solubility encumbers its development into an oral anticancer drug with clinical promise. Here we report the synthesis of 9 third-generation, water-soluble

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持